Live donor study - implications of kidney donation on cardiovascular risk with a focus on lipid parameters including lipoprotein a

Association of age and BMI with kidney function and mortality: a cohort study

(2015) Jun Ling Lu et al.   Lancet Diabetes & Endocrinology

Risk of End-Stage Renal Disease Following Live Kidney Donation

(2014) Abimereki D. Muzaale et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Causes and consequences of lipoprotein(a) abnormalities in kidney disease

(2013) Florian Kronenberg   Clinical and Experimental Nephrology

Long-term risks for kidney donors

(2013) Geir Mjøen et al.   KIDNEY INTERNATIONAL

Uremic Toxin Development in Living Kidney Donors

(2013) Megan Rossi et al.   TRANSPLANTATION

Oxidized phospholipids on apoB-100-containing lipoproteins: a biomarker predicting cardiovascular disease and cardiovascular events

(2011) Adam Taleb et al.   Biomarkers in Medicine

Long-Term Renal Function and Cardiovascular Disease Risk in Obese Kidney Donors

(2009) M. M. Tavakol et al.   Clinical Journal of the American Society of Nephrology

Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts

(2009) F. Afshinnia et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Short-Term Outcomes for Obese Live Kidney Donors and Their Recipients

(2009) Peter P. Reese et al.   TRANSPLANTATION